On November 7, 2014, the company announced that it has extended its plan duration till November 6, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,550 KRW | +2.03% | -0.85% | -10.37% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-10.37% | 12Cr | |
+16.31% | 4.23TCr | |
+16.11% | 2.13TCr | |
+19.33% | 1.53TCr | |
+18.71% | 1.44TCr | |
+52.78% | 1.28TCr | |
-0.05% | 678.76Cr | |
-12.40% | 658.31Cr | |
-8.87% | 572.55Cr | |
+14.28% | 550.82Cr |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till November 7, 2013.